Procurement Summary
Country: Czech Republic
Summary: Dns Lp 2026-013 - Fremanezumab 2026
Deadline: 05 Jun 2026
Posting Date: 26 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 142064198
Document Ref. No.: SZ KZAS/037695/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: CZK 40573000
CPV Classification
33652100 - Antineoplastic agents
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
The subject of the public contract is the provision of continuous supplies of medicinal products with the active substance FREMANEZUMAB for the needs of the contracting authority, as a provider of health services (not for the needs of resale/dispensing), including their direct shipment to pharmacies individual spin-off plants of the contracting authority, on the basis of a framework agreement concluded with one selected supplier for a period of 24 months from the conclusion of the framework agreement. Antineoplastics
DBID: 5123 System number: P26V00000176 File number: SZ KZAS/037695/2026 According to the law: No. 134/2016 Coll. Registration number in VVZ: Z2026-012056 Dynamic purchasing system: A dynamic purchasing system for the supply of medicinal products Start date: 25/05/2026 Offer submit by: 05/06/2026 10:00 Estimated value: 40, 573, 000 CZK without VAT
Documents
Tender Notice
45f0d4f427dd1989cc967ff50014faf9.vyzva.k.podani.nabidky.dns.lp.fremanezumab.2026.pdf
2cefbb4d46376fb1185b52bc701ff611.01.specifikace.a.podklad.pro.zpracovani.cenove.nabidky.fremanezumab.2026.xlsx
3be1cbd87a2c210d8df209deb29f1797.02.ramcova.smlouva.fremanezumab.2026.docx